The Effect of Affirmation During Non-Stress Test on Pain, Anxiety, Fear, and Stress
NST-AFFIRMATIO
2 other identifiers
interventional
90
1 country
1
Brief Summary
This study will examine whether positive affirmations used during the Non-Stress Test (NST) can help reduce pain, anxiety, fear, and stress in pregnant women. The NST is a routine test used during pregnancy to assess fetal well-being. In this randomized controlled study, 90 pregnant women will participate. Some participants will repeat affirmation statements during the NST, while others will receive standard care. Pain, anxiety, fear, and stress levels will be measured before and after the NST. The goal of the study is to understand whether affirmations can make the NST experience more comfortable for pregnant women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pregnancy
Started Nov 2025
Shorter than P25 for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2026
CompletedFirst Submitted
Initial submission to the registry
June 4, 2026
CompletedFirst Posted
Study publicly available on registry
June 25, 2026
CompletedJune 25, 2026
June 1, 2026
6 months
June 4, 2026
June 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety Level
Anxiety level will be assessed using the State Anxiety Inventory before and after the Non-Stress Test. Higher scores indicate higher anxiety levels.
Before and immediately after the Non-Stress Test
Study Arms (3)
Affirmation Group 1
EXPERIMENTALPregnant women with a normal pregnancy process will receive affirmation practice during the Non-Stress Test. During the NST procedure, participants will repeat positive affirmation statements to support relaxation and reduce pain, anxiety, fear, and stress.
Affirmation Group 2
EXPERIMENTALPregnant women who require a repeated Non-Stress Test due to decreased fetal movements or pain will receive affirmation practice during the Non-Stress Test. During the NST procedure, participants will repeat positive affirmation statements to support relaxation and reduce pain, anxiety, fear, and stress.
Control Group
NO INTERVENTIONParticipants in this arm did not receive the affirmation intervention during NST.
Interventions
Pregnant women in the affirmation groups will repeat positive affirmation statements during the Non-Stress Test. The affirmation practice will be applied during the NST procedure to support relaxation and reduce pain, anxiety, fear, and stress.
Eligibility Criteria
You may qualify if:
- Pregnant women admitted to the clinic for the Non-Stress Test
- Pregnant women between 32 and 41 weeks of gestation
- Turkish citizens
- Women aged 20 to 35 years
- Women who voluntarily agree to participate in the study and provide informed consent
- Women who have emptied their bladder immediately before the NST
- Women who have eaten at least two hours before the NST
You may not qualify if:
- High-risk pregnancy, such as preeclampsia or multiple pregnancy
- Inability to read and write Turkish
- Any health problem in the mother or fetus
- Known psychiatric disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Esenler Maternity and Child Diseases Hospital
Istanbul, 34668, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
June 4, 2026
First Posted
June 25, 2026
Study Start
November 10, 2025
Primary Completion
May 5, 2026
Study Completion
May 5, 2026
Last Updated
June 25, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the study includes sensitive health-related data from pregnant women. Participant confidentiality and privacy will be protected, and the data will be used only for the purposes of this study and related scientific reporting.